ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,412Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 2343

$877K Total Retail Price of All Prescriptions

Rank: 199 out of 2343

576 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

39% of this provider’s 576 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

5% of this provider’s 16,517 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 1,216 1,091 1 7
ALENDRONATE SODIUM 823 694 2 28
GLYBURIDE 604 514 R 3 62
NAPROXEN 589 475 10 4 108
SIMVASTATIN 566 504 5 1
DIOVAN HCT 551 472 6 63
OMEPRAZOLE 541 451 7 4
GLIPIZIDE XL 497 426 10 8 84
ACETAMINOPHEN-CODEINE 471 407 S3 9 112
METFORMIN HCL 470 366 10 9
PRAVASTATIN SODIUM 367 279 11 15
CARVEDILOL 356 321 12 27
AMLODIPINE BESYLATE 348 302 13 5
ATORVASTATIN CALCIUM 337 328 14 10
VENTOLIN HFA 327 261 15 79
RANITIDINE HCL 285 240 16 43
TRAMADOL HCL 283 246 17 25
SINGULAIR 279 228 18 100
LOSARTAN-HYDROCHLOROTHIAZIDE 249 201 19 64
LOPERAMIDE 245 221 10 20 238
IBUPROFEN 233 188 21 75
DOXAZOSIN MESYLATE 232 222 22 98
MECLIZINE HCL 231 199 23 103
DIOVAN 225 199 24 23
GABAPENTIN 220 176 25 16
COLCRYS 210 186 26 166
FENOFIBRATE 206 170 27 94
DILTIAZEM 24HR CD 204 179 28 83
DONEPEZIL HCL 198 187 29 21
LOSARTAN POTASSIUM 188 185 30 19
ADVAIR DISKUS 183 127 31 34
TRICOR 181 155 32 96
FEXOFENADINE HCL 180 164 33 240
NIASPAN 177 132 34 141
LEVOCETIRIZINE DIHYDROCHLORIDE 173 157 35 223
ZOLPIDEM TARTRATE 173 146 35 24
LISINOPRIL 162 132 37 3
DILTIAZEM 24HR ER 154 154 38 76
FLUTICASONE PROPIONATE 149 117 39 46
HYDROCORTISONE VALERATE 142 112 40 328
PROAIR HFA 130 92 41 86
ACTOS 124 106 42 125
CLOBETASOL PROPIONATE 121 113 43 263
FLOVENT HFA 119 88 44 213
INDOMETHACIN 117 106 R 45 434
SINGLE USE SWAB 116 102 46 241
MONTELUKAST SODIUM 111 91 47 181
LOVASTATIN 110 95 48 47
BISOPROLOL-HYDROCHLOROTHIAZIDE 108 104 49 151
VALSARTAN-HYDROCHLOROTHIAZIDE 107 89 50 320
NAMENDA 102 102 51 36
THEOPHYLLINE ANHYDROUS 97 84 52 231
ROPINIROLE HCL 90 90 53 124
JANUVIA 86 73 54 50
HYDROCHLOROTHIAZIDE 84 53 55 11
ALCOHOL SWABS 82 65 56 303
DETROL LA 79 78 57 150
ALCOHOL PREP PADS 78 58 58 284
BETAMETHASONE DIPROPIONATE 77 65 59 284
TAMSULOSIN HCL 75 75 60 29
PREDNISONE 74 58 61 37
DILTIAZEM ER 71 68 62 207
LEVOTHYROXINE SODIUM 70 46 63 2
AMOXICILLIN 70 57 63 118
PATANOL 69 59 65 310
AZITHROMYCIN 69 62 65 39
HYDROXYZINE HCL 68 63 R 67 265
HYDRALAZINE HCL 63 59 68 92
PROCTOZONE-HC 62 62 69 208
METHYLPREDNISOLONE 59 49 70 122
GLIPIZIDE ER 57 37 71 115
LANTUS 57 57 71 51
NIFEDICAL XL 56 56 73 148
FUROSEMIDE 56 50 73 6
BENICAR HCT 56 48 73 156
LIPITOR 55 50 76 78
INSULIN SYRINGE 54 44 77 102
CARBIDOPA-LEVODOPA 54 54 77 85
POLYETHYLENE GLYCOL 3350 54 51 77 54
AMMONIUM LACTATE 50 39 80 228
LIDODERM 50 48 80 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.